ARCHIVES

Wyden Hearing On Taxol Agreements Mangles Facts In Attempt To Protect ‘Public Interest’

This article is from The Cancer Letter archive.

Vol. 17 No. 32 | August 9, 1991

Download PDF Visit The Full Archive

Related Articles

Bevacizumab Improves PFS In Advanced Kidney Cancer

July 27, 2007

Clinton Endorses Legislation Preventing Genetic Discrimination

May 23, 1997

NCI Directory Delayed

January 27, 1984

In Brief: Newell Denies He’s Leaving For Job On West Coast, Says He Is A “Free Agent”

November 4, 1977

In Brief: AACR Grants Record Number Of Awards To Young Investigators; Kersey Leads ASBMT

April 24, 1998

NCI Cooperative Group Clinical Trials Approved

September 24, 2010